The Curbsiders Internal Medicine Podcast

#238 DVT / PE Triple Distilled

4 snips
Oct 22, 2020
Dr Oren Friedman and Dr Michael Streiff discuss VTE diagnosis, risk stratification, anticoagulation choice, treatment duration, workup for unprovoked BTE, anticoagulation in special populations, and the indications for using IVC filters.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ADVICE

Prefer Apixaban for Outpatient PE

  • For low-risk PE patients treated outpatient, apixaban is the preferred DOAC.
  • Other factor Xa inhibitors are options but apixaban has the best evidence for safety and efficacy.
ADVICE

Treat Duration: Provoked vs Unprovoked VTE

  • Treat provoked VTE for 3 months if the causing risk factor is resolved.
  • For unprovoked VTE, lean toward lifelong anticoagulation unless strong reasons to stop.
ADVICE

Use HURDOO Score for Recurrence Risk

  • Use the HURDOO score in women to assess VTE recurrence risk and guide anticoagulation duration.
  • Women overweight or older than 65 are not low risk and should continue anticoagulation.
Get the Snipd Podcast app to discover more snips from this episode
Get the app